# Huaier Granule in Treating Women With Triple Negative Breast Cancer

> **NCT02615457** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 300 (estimated)

## Conditions studied

- Triple Negative Breast Cancer

## Interventions

- **DRUG:** Huaier Granule

## Key facts

- **NCT ID:** NCT02615457
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2025-10
- **Final completion:** —
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02615457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02615457, "Huaier Granule in Treating Women With Triple Negative Breast Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02615457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*